The research demonstrates how schisandrin B reduces apoptosis in neurons, suggesting protective effects against Alzheimer’s disease.
In the present study, we investigated the neuroprotective effects of schisandrin B on amyloid-β1–42-induced toxicity and its potential mechanisms in rat cortical neuron cells. Amyloid β1–42 significantly reduced cell viability and increased apoptosis. Pretreatment with schisandrin B prior to amyloid-β1–42 exposure significantly elevated cell viability and reduced apoptosis. The anti-apoptotic effect of schisandrin B in rat cortical neurons was mediated by up-regulation of the anti-apoptotic protein Bcl-2 and down-regulation of the pro-apoptotic protein Bax. Schisandrin B also reduced the release of mitochondrial cytochrome c into cytosol and decreased caspase-9 and caspase-3 activities. Furthermore, schisandrin B increased activities of anti-oxidant reduced glutathione and decreased production of oxidative glutathione. Taken together, these results suggest that schisandrin B protected primary cultures of rat cortical cells against amyloid-β1–42-induced neurotoxicity through anti-apoptosis involved in a mitochondria-mediated pathway and anti-oxidant action. Schisandrin B may represent a potential treatment strategy for Alzheimer’s disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: